Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Challenges in pediatric kidney transplantation : a practical guide / / edited by Katherine E. Twombley
| Challenges in pediatric kidney transplantation : a practical guide / / edited by Katherine E. Twombley |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (429 pages) |
| Disciplina | 617.9540083 |
| Soggetto topico |
Pediatric nephrology
Kidneys - Transplantation Transplantation of organs, tissues, etc. in children Trasplantament renal Nefrologia pediàtrica Trasplantament d'òrgans |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-74783-2 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Contents -- Contributors -- Part I: Immunologic Challenges -- 1: Immunologic Challenges Pre-transplant -- Introduction -- What Is Human Leukocyte Antigen (HLA)? -- Pre-transplant -- How Does Sensitization Occur? -- Why Is HLA Compatibility Important? -- Epitope Mismatch -- How Are HLA Antibodies Detected and HLA Matching Performed? -- Antibody Detection -- Cell-Based Assays -- Solid-Phase Assays -- Is Median Fluorescent Intensity (MFI) Signal a Surrogate Measure of the Level of HLA Antibody? -- Peri-transplant -- The Virtual Crossmatch (vXM) in Transplantation -- Unexpected Crossmatch Scenarios -- Clinical Scenarios and Interpretation of Crossmatch Results in Kidney Transplantation -- Conclusion -- Questions and Answers with Explanation -- References -- 2: Challenges in Post-transplant Immunologic Monitoring -- Challenges in Post-transplant Immunologic Monitoring -- Conventional Monitoring Post-Transplant -- Serum Creatinine (Graft Function) -- Drug Monitoring and Variability -- Surveillance Monitoring of Donor-Specific Antibodies -- Non-HLA Antibodies -- Surveillance Biopsies (SBs) -- Innovative Biomarkers for Immunologic Monitoring Post-transplant -- Donor-Derived Cell-Free DNA (dd-cfDNA) -- Urinary Biomarkers -- Molecular Diagnostics -- The Future of Post-transplant Immune Monitoring -- Q& -- A -- Bibliography -- 3: Rejection Challenges: Diagnosis and Management -- A Brief History of Rejection -- An Evolving Paradigm of Rejection: From Discreet Episodic Events to a Fluctuating Continuum of Immune Alloreactivity -- Pathophysiology of Alloimmune Activation and Downstream Processes -- T Cell Development and Activation -- T Cell Migration and Mechanisms of Injury in T Cell-Mediated Rejection with the Allograft -- B Cell Development and Activation -- Alloantibodies and Antibody-Mediated Rejection -- Alloimmune Chronicity.
Detecting Rejection and Monitoring Its Course -- Clinical Monitoring and Biopsy Indication -- Surveillance Biopsies -- Follow-Up Biopsies -- Biomarkers for Rejection -- Gene Expression Signatures -- Chemokines -- Metabolomics -- Cell-Free DNA -- Predisposing Risk Factors for Rejection -- Recipient-Related Risks -- Donor-Recipient Interface -- Donor-Related Risks -- Silent Sensitization -- HLA Mismatch -- Post-transplant Factors -- Hyperacute Rejection -- Acute T Cell-Mediated Rejection (TCMR) -- Clinical and Histological Features -- Treatment of TCMR -- Corticosteroids -- Lymphocyte-Depleting Therapies -- Late Acute TCMR -- B Cell-Rich and Plasma Cell-Rich Acute Rejection -- B Cell-Rich Rejection -- Plasma Cell-Rich Acute Rejection -- Active Antibody-Mediated Rejection (AMR) -- Clinical and Histological Features -- Treatment of AMR -- Plasmapheresis and IVIG -- Rituximab -- Bortezomib -- Emerging Treatments -- Response to Treatment -- Chronic Active TCMR -- Clinical and Histological Features -- Management -- Chronic Active AMR -- Clinical and Histological Features -- Management -- Emerging Therapies -- Post Rejection Infection Prophylaxis -- Special Circumstances: Infection and Rejection -- AGPN and Rejection -- BK Virus and Rejection -- Case Studies -- References -- Part II: Infectious Challenges -- 4: Pretransplant Donor and Recipient Infectious Challenges -- Pretransplant Infectious Disease Evaluation -- Evaluation of the Pediatric Kidney Transplant Candidate -- HIV and Hepatitis Viruses -- Cytomegalovirus/Epstein-Barr Virus Serostatus of Donor and Recipient -- Cytomegalovirus -- Epstein-Barr Virus -- Mycobacterium tuberculosis -- Fungal Infections and Endemic Mycoses -- Parasitic Infections -- COVID-19 -- Urinary Tract Infections -- PHS Increased Risk Donors -- Window Period Duration and the Risk of Virus Transmission. Outcomes of PHS Increased Risk Donors in Pediatric Kidney Transplantation -- Informed Consent -- Posttransplant Testing -- Immunizations -- Preparing the Dialysis Patient for Transplantation -- Vaccine Schedule: Current American Academy of Pediatrics Recommendations -- Summary of recommendations with end stage kidney disease, including transplant candidates [62-64] -- Hepatitis B -- Influenza Vaccine -- Pneumococcal Vaccine [68, 69] -- Special Situations [70, 71] -- Household/Live Donor Vaccination -- Live Vaccines -- Varicella Vaccine -- Measles-Mumps-Rubella Vaccine -- Recombinant and Inactivated ("Killed") Vaccines -- DTaP/Tdap/dT Vaccine -- Poliovirus Vaccine -- Haemophilus Influenzae Type B Vaccine -- Hepatitis A Vaccine -- Hepatitis B Vaccine -- Meningococcal Vaccine -- Human Papillomavirus -- Updating Immunizations for the Dialysis Patient Awaiting Transplant -- Questions -- References -- 5: Post-transplant Recipient Infectious Challenges -- Introduction -- Opportunistic Post-Kidney Transplant Infections (CMV, EBV, and BK Virus and PJP) -- Cytomegalovirus (CMV) -- Risk Factors -- Clinical Presentation -- Screening -- Prophylaxis and Preemptive Therapy -- Treatment -- BK Virus -- Risk Factors -- Clinical Presentation -- Screening -- Treatment -- Epstein-Barr Virus -- Risk Factors -- Clinical Presentation -- Screening -- Treatment -- Pneumocystis jirovecii pneumonia (PJP) -- Resurgent Viral Infection Outbreaks: Measles and Mumps -- Cancer Risks -- Cancer Incidence -- Cancer Risk Factors -- Immunosuppression Burden -- EBV Recipient-Donor Sero-Mismatch -- Time Since Transplant -- HLA Haplotypes -- Pre-transplant Malignancy -- Age -- Gender -- Race -- Donor Source -- Recombinant Growth Hormone (rGH) Use -- Cancer Prevention Strategies -- Cancer Treatment -- Cancer Outcomes -- Urinary Tract Infections (UTI) -- Prevalence -- Risk Factors. Prevention -- Treatment -- Asymptomatic Bacteriuria -- Outcomes -- MOC Questions -- References -- Part III: Disease Challenges -- 6: Urological Considerations for Pediatric Renal Transplantation: CAKUT Challenges -- Urological Complications Post-transplant -- References -- 7: Rheumatologic Challenges -- Systemic Lupus Erythematosus -- Introduction -- Clinical Course of Renal Involvement and Outcomes -- Renal Transplantation in Lupus Nephritis -- Recurrence of Lupus Nephritis Post-transplantation -- Health Disparities in Systemic Lupus Erythematosus and Lupus Nephritis -- Conclusion -- IgA Vasculitis -- Introduction -- Clinical Course of Renal Involvement and Outcomes -- Renal Transplantation in IgAV Nephritis and Outcomes -- ANCA-Associated Vasculitis -- Introduction -- Clinical Course of Renal Involvement and Outcomes -- Renal Transplantation in Childhood AAV and Outcomes -- Conclusion -- References -- 8: Recurrent Disease Challenges in Pediatric Kidney Transplantation -- Introduction -- Atypical Hemolytic Uremic Syndrome (aHUS) -- Nature and Frequency of Primary Disease -- Considerations for Transplant Planning -- Risk Factors for Recurrence and Treatment of Recurrence -- Risk of Disease Recurrence in the Era of Eculizumab -- Additional Post-transplant Considerations -- C3 Glomerulopathy (C3G) -- Nature and Frequency of C3G -- Considerations for Transplant Planning -- Risk Factors for Recurrence and Treatment of C3G Recurrence -- IgA Nephropathy -- Nature and Frequency of IgA Nephropathy (IgAN) -- Risk Factors for Recurrence -- Considerations for Transplant Planning -- Treatment of IgAN Recurrence -- Impact of IgAN on Graft Function and Survival -- IgA Vasculitis (Henoch-Schonlein Purpura) -- Lupus Nephritis -- Nature and Frequency of Disease -- Risk for Disease Recurrence -- Considerations for Transplant Planning. Impact of RLN on Graft Function and Survival -- Other Diseases -- Primary Hyperoxaluria Type 1 (Oxalosis) -- Membranous Nephropathy -- Conclusion -- References -- 9: Nephrotic Syndrome Challenges: An Old Recurring Problem -- APOL1 -- Mechanism of Renal Injury -- Second Hit Modifiers -- Clinical Implications -- Pre-transplant Nephrectomy -- Proteinuria -- WT1 Mutation -- Disease Recurrence -- Genetic Mutations -- Living vs Deceased Donation -- Clinical Features Predictive of DR -- Circulating Factor and DR -- Treatment of Disease Recurrence -- Plasmapheresis -- Immunoadsorption -- Rituximab -- Cyclosporine -- Lipid Apheresis -- Questions -- Bibliography -- 10: Challenges of Maintaining Adequate Health and Well-Being, Growth, Nutrition, and Development in Pediatric Transplant Recipients -- Vaccinations -- Pre-transplant -- Post-transplant -- Vaccines and Travel -- Nutritional Challenges -- Pre-transplant -- CKD 2-5 Pre-dialysis -- Hemodialysis -- Peritoneal Dialysis -- Nutritional Management in CKD and Dialysis -- Enteral Nutrition Support -- Post-transplant -- Appetite and Weight -- Transition from Enteral to Oral Feeding -- Medication Effects -- Nutritional Management Post-transplant -- Food Safety -- Growth Challenges -- Growth Hormone Physiology -- Growth and CKD -- Growth After Kidney Transplant -- Outcomes -- Growth Hormone Utilization -- Indications and Contraindications for Growth Hormone -- Work-Up, Treatment, and Monitoring -- Work-Up -- Treatment -- Monitoring -- Safety of Growth Hormone in Transplant Recipients -- Metabolic Bone Disease -- Pathophysiology of CKD-BMD -- Bone Mineral Monitoring -- Post-transplant Bone Metabolism -- PTH, FGF-23, and Hypophosphatemia -- Hypomagnesemia -- Vitamin D -- Immunosuppression -- Role of Sex Hormones -- Prevention Strategies -- Steroid Minimization -- Diet and Physical Activity -- Treatment. Pharmacologic Therapies. |
| Record Nr. | UNINA-9910488710503321 |
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Ethical Issues in Pediatric Organ Transplantation / / edited by Rebecca A. Greenberg, Aviva M. Goldberg, David Rodríguez-Arias
| Ethical Issues in Pediatric Organ Transplantation / / edited by Rebecca A. Greenberg, Aviva M. Goldberg, David Rodríguez-Arias |
| Edizione | [1st ed. 2016.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016 |
| Descrizione fisica | 1 online resource (XXVIII, 340 p. 4 illus.) |
| Disciplina | 617.9540083 |
| Collana | International Library of Ethics, Law, and the New Medicine |
| Soggetto topico |
Ethics
Surgical transplantation Pediatrics Medical ethics Medicine—Philosophy Transplant Surgery Theory of Medicine/Bioethics Philosophy of Medicine |
| ISBN | 3-319-29185-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction – Rodríguez-Arias, Greenberg, and Goldberg -- 1.0 Living Donation -- 1.1 Minors as organ donors – Freedman Ross, Parker and Thistelwaite -- 1.2 Living donors for fulminant hepatic failure in children - Segedi and Grant -- 1.3 The Ethics of Persuasion: Evaluating the ethical limits on attempting to persuade families to donate the organs of deceased family members - Chandler and Gruben -- 1.4 Misattributed Paternity - Freeman and Parker -- 2.0 Deceased Donation -- 2.1 Death determination in children - Shemie and Ortega-Deballon -- 2.2 Controlled donation after cardiac death (2 chapters) -- 2.2.1 Controlled donation after cardiac death in pediatrics - Talati and Frader -- 2.2.2 Ethical and organizational challenges in controlled donation after cardiac death for children – Harrison -- 3.0 Emerging Technology -- 3.1 Ethical issues in pediatric bowel rehabilitation and small bowel transplantation – Fecteau -- 3.2 Vascularized Composite Allotransplantation (VCA) - Zlotnik Shaul, Wright, Flynn, Borschel, Hanson, and Zuker -- 3.3 Media management – Amaral and Feudtner -- 4.0 Allocating Organs -- 4.1Transplantation for pediatric foreign nationals - Fortin and Greenberg -- 4.2 Neurodevelopmental status as a criterion for solid organ transplant eligibility – Wightman, Diekema and Smith -- 5.0 Recipient Issues -- 5.1 Psychosocial aspects of pediatric organ transplantation – Derrington, Goldberg and Frader -- 5.2 Ethical issues in adolescents and transplantation – Goldberg and Fine -- Conclusion - Rodríguez-Arias, Greenberg, Goldberg. |
| Record Nr. | UNINA-9910255341503321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pediatric Solid Organ Transplantation : A Practical Handbook / / Ron Shapiro [and three others], editors
| Pediatric Solid Organ Transplantation : A Practical Handbook / / Ron Shapiro [and three others], editors |
| Edizione | [First edition.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore Pte Ltd., , [2023] |
| Descrizione fisica | 1 online resource (530 pages) |
| Disciplina | 617.9540083 |
| Soggetto topico | Transplantation of organs, tissues, etc. in children |
| ISBN | 981-19-6909-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part I: Renal Transplant -- Pediatric Transplantation Historical View -- Transplant Immunobiology -- Deceased Donor Allocation Policy and Kidney Allocation System on Young Pediatric Recipients -- Donor-Recipient Size Mismatch in Pediatric Renal Transplantation -- Medical Evaluation of Living Kidney Donor in Childrens -- Surgical Management of Renal Transplant Patient -- Management of the Pediatric Renal Transplant with Posterior Urethral Valves for Successful Transplantation -- Induction Therapy in pediatric Transplantation Current Guideline -- Transition in Renal Trasnplant Patients -- Induction in Highly Sensitized Pediatric Renal Transplant Recipients -- Pediatric ABO-Incompatible Kidney Transplantation -- Immune Monitoring after Pediatric Renal Transplant and Approach to the Diagnosis and Management of Rejection -- Overview of Immunosuppressive Therapy in Pediatric Renal Transplantation -- Pediatric Immunosuppression Adherence -- Diagnosis and Treatment of Antibody Meditated Rejection -- Acute Vascular Rejection -- Infectious Complication in Pediatric Renal Transplant -- Hypertension post Renal Transplantation -- Recurrent Renal Disease after Transplant -- Post-Transplant Lymphoproliferative Disorders -- Management of Chronic Renal Allograft Dysfunction and when to Re-transplant -- Part II: Intestinal Transplant -- Indications and Management of Pediatric Intestinal Transplantation -- Intestinal and Multivesicular Transplantation in Children outcomes and Complications -- Long-term Management of Intestinal Transplant -- Part III: Pancreatic Transplant -- Pancreatic Transplant in Children -- Islet Auto Transplantation (TPIAT) and Management -- Pancreas: Autologous Islet Cell Transplantation in Children with Chronic Pancreatitis -- Part IV: Heart Transplant -- Pediatric Heart Transplantation—Indications and Outcomes -- Heart Transplantation Immunosuppression -- Heart: Combined Heart/Lung and Abdominal Transplantation -- Part V: Liver Transplant -- Perioperative management of Liver Transplantation -- Liver Transplantation in Children -- Combined Liver-Kidney Transplantation for Primary Hyperoxaluria Type 1 -- Immune Monitoring after Pediatric Liver Transplantation -- Immunosuppression in Liver transplantation -- Hepatocyte Transplantation -- Liver: SPLIT Liver Transplantation: How to Make it Right! -- Part VI: Lung Transplant.-Pediatric Lung Transplantation: Indications and Outcomes -- Size‐reduced Lung Transplantation in children -- Pediatric Lung and Heart-Lung Transplantation -- International Pediatric Lung and Heart–Lung Transplantation Experience. |
| Record Nr. | UNINA-9910678249503321 |
| Singapore : , : Springer Nature Singapore Pte Ltd., , [2023] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pediatric solid organ transplantation [[electronic resource]]
| Pediatric solid organ transplantation [[electronic resource]] |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Malden, Mass. ; ; Oxford, : Blackwell Pub., 2007 |
| Descrizione fisica | 1 online resource (506 p.) |
| Disciplina | 617.9540083 |
| Altri autori (Persone) | FineRichard N |
| Soggetto topico | Transplantation of organs, tissues, etc. in children |
| ISBN |
1-282-11820-X
9786612118203 0-470-76073-7 1-4443-1272-3 1-4443-1273-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Preface to the Second Edition; Preface to the First Edition; Contributors; Section 1 Immunology and Genetics; 1 The Immune Response to Organ Allografts; 2 Allorecognition Pathway; 3 Costimulation; 4 The HLA System and Histocompatibility Testing for Organ Transplantation; 5 Gene Polymorphisms and Pharmacogenomics; 6 Genomics and Proteomics as Research Tools; 7 Tolerance: A Review its Mechanisms in the Transplant Setting; Section 2 Immunosuppression and its Complications; 8 Mechanisms of Action of Immunosuppressive Agent; 9 Induction and Maintenance Immunosuppression
10 Novel Immunosuppressants11 Therapies for the Allosensitized Patien; 12 Infections Post-Transplantation; 13 Post-Transplant Lymphoproliferative Disorders and Malignancy; 14 Organ Toxiciti; Section 3 Kidney Transplantation; 15 Historical Note; 16 Recipient Characteristics; 17 Evaluation of the Candidate; 18 Donor Evaluation, Surgical Technique and Perioperative Management; 19 Pathology of the Kidney Allograft; 20 Post-Transplant Management; 21 Outcomes and Risk Factors; Section 4 Liver Transplantation; 22 Historical Notes; 23 Recipient Characteristics; 24 Evaluation of the Candidate 25 Donor Evaluation, Surgical Technique and Perioperative Management26 Pathology of the Liver Allograft; 27 Post-Transplant Management; 28 Outcomes and Risk Factors; Section 5 Heart Transplantation; 29 Historical Notes; 30 Recipient Characteristics; 31 Evaluation of the Candidate; 32 Donor Evaluation, Surgical Technique and Perioperative Management; 33 Pathology of the Cardiac Allograft; 34 Post-Transplant Management; 35 Outcomes and Risk Factors; Section 6 Lung and Heart-Lung Transplantation; 36 Historical Notes; 37 Recipient Characteristics; 38 Evaluation of the Candidate 39 Donor Evaluation, Surgical Technique and Perioperative Management40 Pathology of the Lung Allograft; 41 Post-Transplant Management; 42 Outcomes and Risk Factors; Section 7 Intestinal Transplantation; 43 Historical Notes; 44 Recipient Characteristics; 45 Evaluation of the Candidate; 46 Donor Evaluation, Surgical Technique and Perioperative Management; 47 Pathology of the Intestinal Allograft; 48 Post-Transplant Management; 49 Outcomes and Risk Factors; Section 8 Special Issues after Pediatric Transplantation; 50 Growth and Puberty; 51 Cognitive Development 52 Psychosocial Adaptation and Adherence53 Pregnancy; 54 Gynecologic Issues; 55 Transition to Adult Care; Index |
| Record Nr. | UNINA-9910143131603321 |
| Malden, Mass. ; ; Oxford, : Blackwell Pub., 2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pediatric solid organ transplantation [[electronic resource]]
| Pediatric solid organ transplantation [[electronic resource]] |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Malden, Mass. ; ; Oxford, : Blackwell Pub., 2007 |
| Descrizione fisica | 1 online resource (506 p.) |
| Disciplina | 617.9540083 |
| Altri autori (Persone) | FineRichard N |
| Soggetto topico | Transplantation of organs, tissues, etc. in children |
| ISBN |
1-282-11820-X
9786612118203 0-470-76073-7 1-4443-1272-3 1-4443-1273-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Preface to the Second Edition; Preface to the First Edition; Contributors; Section 1 Immunology and Genetics; 1 The Immune Response to Organ Allografts; 2 Allorecognition Pathway; 3 Costimulation; 4 The HLA System and Histocompatibility Testing for Organ Transplantation; 5 Gene Polymorphisms and Pharmacogenomics; 6 Genomics and Proteomics as Research Tools; 7 Tolerance: A Review its Mechanisms in the Transplant Setting; Section 2 Immunosuppression and its Complications; 8 Mechanisms of Action of Immunosuppressive Agent; 9 Induction and Maintenance Immunosuppression
10 Novel Immunosuppressants11 Therapies for the Allosensitized Patien; 12 Infections Post-Transplantation; 13 Post-Transplant Lymphoproliferative Disorders and Malignancy; 14 Organ Toxiciti; Section 3 Kidney Transplantation; 15 Historical Note; 16 Recipient Characteristics; 17 Evaluation of the Candidate; 18 Donor Evaluation, Surgical Technique and Perioperative Management; 19 Pathology of the Kidney Allograft; 20 Post-Transplant Management; 21 Outcomes and Risk Factors; Section 4 Liver Transplantation; 22 Historical Notes; 23 Recipient Characteristics; 24 Evaluation of the Candidate 25 Donor Evaluation, Surgical Technique and Perioperative Management26 Pathology of the Liver Allograft; 27 Post-Transplant Management; 28 Outcomes and Risk Factors; Section 5 Heart Transplantation; 29 Historical Notes; 30 Recipient Characteristics; 31 Evaluation of the Candidate; 32 Donor Evaluation, Surgical Technique and Perioperative Management; 33 Pathology of the Cardiac Allograft; 34 Post-Transplant Management; 35 Outcomes and Risk Factors; Section 6 Lung and Heart-Lung Transplantation; 36 Historical Notes; 37 Recipient Characteristics; 38 Evaluation of the Candidate 39 Donor Evaluation, Surgical Technique and Perioperative Management40 Pathology of the Lung Allograft; 41 Post-Transplant Management; 42 Outcomes and Risk Factors; Section 7 Intestinal Transplantation; 43 Historical Notes; 44 Recipient Characteristics; 45 Evaluation of the Candidate; 46 Donor Evaluation, Surgical Technique and Perioperative Management; 47 Pathology of the Intestinal Allograft; 48 Post-Transplant Management; 49 Outcomes and Risk Factors; Section 8 Special Issues after Pediatric Transplantation; 50 Growth and Puberty; 51 Cognitive Development 52 Psychosocial Adaptation and Adherence53 Pregnancy; 54 Gynecologic Issues; 55 Transition to Adult Care; Index |
| Record Nr. | UNISA-996202010003316 |
| Malden, Mass. ; ; Oxford, : Blackwell Pub., 2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Pediatric solid organ transplantation [[electronic resource]]
| Pediatric solid organ transplantation [[electronic resource]] |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Malden, Mass. ; ; Oxford, : Blackwell Pub., 2007 |
| Descrizione fisica | 1 online resource (506 p.) |
| Disciplina | 617.9540083 |
| Altri autori (Persone) | FineRichard N |
| Soggetto topico | Transplantation of organs, tissues, etc. in children |
| ISBN |
1-282-11820-X
9786612118203 0-470-76073-7 1-4443-1272-3 1-4443-1273-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Preface to the Second Edition; Preface to the First Edition; Contributors; Section 1 Immunology and Genetics; 1 The Immune Response to Organ Allografts; 2 Allorecognition Pathway; 3 Costimulation; 4 The HLA System and Histocompatibility Testing for Organ Transplantation; 5 Gene Polymorphisms and Pharmacogenomics; 6 Genomics and Proteomics as Research Tools; 7 Tolerance: A Review its Mechanisms in the Transplant Setting; Section 2 Immunosuppression and its Complications; 8 Mechanisms of Action of Immunosuppressive Agent; 9 Induction and Maintenance Immunosuppression
10 Novel Immunosuppressants11 Therapies for the Allosensitized Patien; 12 Infections Post-Transplantation; 13 Post-Transplant Lymphoproliferative Disorders and Malignancy; 14 Organ Toxiciti; Section 3 Kidney Transplantation; 15 Historical Note; 16 Recipient Characteristics; 17 Evaluation of the Candidate; 18 Donor Evaluation, Surgical Technique and Perioperative Management; 19 Pathology of the Kidney Allograft; 20 Post-Transplant Management; 21 Outcomes and Risk Factors; Section 4 Liver Transplantation; 22 Historical Notes; 23 Recipient Characteristics; 24 Evaluation of the Candidate 25 Donor Evaluation, Surgical Technique and Perioperative Management26 Pathology of the Liver Allograft; 27 Post-Transplant Management; 28 Outcomes and Risk Factors; Section 5 Heart Transplantation; 29 Historical Notes; 30 Recipient Characteristics; 31 Evaluation of the Candidate; 32 Donor Evaluation, Surgical Technique and Perioperative Management; 33 Pathology of the Cardiac Allograft; 34 Post-Transplant Management; 35 Outcomes and Risk Factors; Section 6 Lung and Heart-Lung Transplantation; 36 Historical Notes; 37 Recipient Characteristics; 38 Evaluation of the Candidate 39 Donor Evaluation, Surgical Technique and Perioperative Management40 Pathology of the Lung Allograft; 41 Post-Transplant Management; 42 Outcomes and Risk Factors; Section 7 Intestinal Transplantation; 43 Historical Notes; 44 Recipient Characteristics; 45 Evaluation of the Candidate; 46 Donor Evaluation, Surgical Technique and Perioperative Management; 47 Pathology of the Intestinal Allograft; 48 Post-Transplant Management; 49 Outcomes and Risk Factors; Section 8 Special Issues after Pediatric Transplantation; 50 Growth and Puberty; 51 Cognitive Development 52 Psychosocial Adaptation and Adherence53 Pregnancy; 54 Gynecologic Issues; 55 Transition to Adult Care; Index |
| Record Nr. | UNINA-9910830666703321 |
| Malden, Mass. ; ; Oxford, : Blackwell Pub., 2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||